Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Home

Showing results (201-210 of 231) with videos related to

Pageof 24
Sort By:
Diabetologia|June 2, 2009
Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuriaL Sibal, A Aldibbiat, S C Agarwal, et al.
Diabetes, Obesity & Metabolism|June 25, 2014
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetesP D Home, G B Bolli, C Mathieu, et al.
Cardiovascular Diabetology|April 26, 2008
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study)Michel Komajda, Paula Curtis, Markolf Hanefeld, et al.
Diabetes Care|March 21, 2025
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 DiabetesGeremia B Bolli, Philip D Home, Francesca Porcellati, et al.
British Medical Journal (Clinical Research Ed.)|October 30, 1982
Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trialR Worth, P D Home, D G Johnston, et al.
Diabetes, Obesity & Metabolism|July 7, 2020
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparisonPhilip D Home, Vanita R Aroda, Lawrence Blonde, et al.
The New England Journal of Medicine|June 7, 2007
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysisPhilip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.
Metabolism: Clinical and Experimental|September 1, 1991
The effects of human proinsulin on glucose turnover and intermediary metabolismS N Davis, P C Butler, M Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 14, 2011
Improved health status with insulin degludec compared with insulin glargine in people with type 1 diabetesP D Home, L Meneghini, U Wendisch, et al.
British Medical Journal (Clinical Research Ed.)|April 18, 1981
Human insulin: study of safety and efficacy in manD R Owens, M K Jones, T M Hayes, et al.
Pageof 24

Showing results (201-210 of 231) with videos related to

Sort By:
Pageof 24
Diabetologia|June 2, 2009
Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuriaL Sibal, A Aldibbiat, S C Agarwal, et al.
Diabetes, Obesity & Metabolism|June 25, 2014
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetesP D Home, G B Bolli, C Mathieu, et al.
Cardiovascular Diabetology|April 26, 2008
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study)Michel Komajda, Paula Curtis, Markolf Hanefeld, et al.
Diabetes Care|March 21, 2025
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 DiabetesGeremia B Bolli, Philip D Home, Francesca Porcellati, et al.
British Medical Journal (Clinical Research Ed.)|October 30, 1982
Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trialR Worth, P D Home, D G Johnston, et al.
Diabetes, Obesity & Metabolism|July 7, 2020
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparisonPhilip D Home, Vanita R Aroda, Lawrence Blonde, et al.
The New England Journal of Medicine|June 7, 2007
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysisPhilip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.
Metabolism: Clinical and Experimental|September 1, 1991
The effects of human proinsulin on glucose turnover and intermediary metabolismS N Davis, P C Butler, M Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 14, 2011
Improved health status with insulin degludec compared with insulin glargine in people with type 1 diabetesP D Home, L Meneghini, U Wendisch, et al.
British Medical Journal (Clinical Research Ed.)|April 18, 1981
Human insulin: study of safety and efficacy in manD R Owens, M K Jones, T M Hayes, et al.
Pageof 24